$1.76
(Market cap
$10,679 Mln
Revenue (TTM)
$2,901 Mln
P/E Ratio
35.9
P/B Ratio
8.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.2 %
-
ROCE
9.5 %
-
Industry P/E
44.07
-
EV/EBITDA
19.8
-
Debt to Equity
0.7
-
Book Value
$--
-
EPS
$4.3
-
Face value
--
-
Shares outstanding
69,264,674
10 Years Aggregate
CFO
$468.09 Mln
EBITDA
$492.14 Mln
Net Profit
$68.66 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Insulet (PODD)
| -47.0 | -23.9 | -38.0 | -52.1 | -23.0 | -7.8 | 18.8 |
|
BSE Sensex
| -11.0 | -1.9 | -8.7 | -7.1 | 6.7 | 9.1 | 11.5 |
|
S&P Midcap 400
| 9.6 | 4.1 | 3.8 | 20.3 | 14.7 | 6.9 | 9.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Insulet (PODD)
| 8.9 | 20.1 | -26.3 | 10.6 | 4.1 | 49.3 | 115.8 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Insulet (PODD)
|
150.6 | 10,678.5 | 2,900.9 | 302.8 | 15.9 | 22.5 | 35.9 | 8.2 |
| 84.8 | 143,804.1 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 23.1 | 2.8 | |
| 17.7 | 9,053.7 | 11,320.0 | -1,098.0 | -2.0 | -16.5 | -- | 1.5 | |
| 246.3 | 6,524.2 | 2,589.9 | 168.8 | 21.4 | 2.5 | 40.6 | 1.0 | |
| 76.2 | 10,408.9 | 3,100.6 | 586.7 | 14.2 | 12.9 | 17.9 | 2.2 | |
| 71.4 | 7,859.1 | 13,384.0 | 395.0 | 5.2 | 11.2 | 20.8 | 2.5 | |
| 433.6 | 148,769.7 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 51 | 9.1 | |
| 25.7 | 25,447.4 | 17,706.2 | 972.5 | 8.7 | 8.8 | 22.7 | 1.9 | |
| 131.5 | 5,742.7 | 2,811.2 | -1,008.8 | -7.9 | -29.2 | 2162 | 1.9 | |
| 453.5 | 168,195.9 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 24.9 | 3.3 |
Shareholding Pattern
View DetailsAbout Insulet (PODD)
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin... delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Address: 100 Nagog Park, Acton, MA, United States, 01720 Read more
-
President, CEO & Director
Dr. James R. Hollingshead Ph.D.
-
President, CEO & Director
Dr. James R. Hollingshead Ph.D.
-
Headquarters
Acton, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Insulet (PODD)
What is the current share price of Insulet Corporation (PODD) Today?
The share price of Insulet Corporation (PODD) is $150.60 (NASDAQ) as of 14-May-2026 10:39 EDT. Insulet Corporation (PODD) has given a return of -23.03% in the last 3 years.
What is the current PB & PE ratio of Insulet Corporation (PODD)?
The P/E ratio of Insulet Corporation (PODD) is 35.94 times as on 12-May-2026, a 18 discount to its peers’ median range of 44.07 times.
The P/B ratio of Insulet Corporation (PODD) is 8.19 times as on 12-May-2026, a 183 premium to its peers’ median range of 2.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
81.29
|
13.26
|
|
2024
|
46.23
|
15.96
|
|
2023
|
73.48
|
20.69
|
|
2022
|
4,481.13
|
43.27
|
|
2021
|
1,105.68
|
33.39
|
What is the 52 Week High and Low of Insulet Corporation (PODD)?
The 52-week high and low of Insulet Corporation (PODD) are Rs 354.88 and Rs 145.59 as of 14-May-2026.
What is the market cap of Insulet Corporation (PODD)?
Insulet Corporation (PODD) has a market capitalisation of $ 10,679 Mln as on 12-May-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Insulet Corporation (PODD)?
Before investing in Insulet Corporation (PODD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.